L-768242

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameL-768242
Drug Alias NameL-768242
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor agonists
TargetsCannabinoid CB2 receptor
Therapy Area/IndicationsPsychotic DisordersInflammationHypersensitivity +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Canada Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Canada Inc
Active IndicationsN/A
Inactive IndicationsPsychotic DisordersInflammationHypersensitivity +[6] 

Other Information

ATC CodeN/A
Related LinksN/A